Abbvie, Inc. (ABBV) Earnings
|
Expand Research on ABBV
Next EPS Date | 4/26/24 | EPS Growth Rate | -7.7% |
---|---|---|---|
Average EPS % Beat Rate | +1.2% | Revenue Growth Rate | -2.5% |
Average % Move 1-Wk after EPS | +0.1% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
4/26/24 | Q124 | N/A | $2.27 | N/A | N/A | $11.93B | = | N/A | N/A | ||
2/2/24 | Q423 | $2.79 | $2.77 | +$0.02 | $14.3B | $14.01B | = | Details | |||
10/27/23 | Q323 | $2.95 | $2.87 | +$0.08 | $13.93B | $13.71B | Details | ||||
7/27/23 | Q223 | $2.91 | $2.87 | +$0.04 | $13.87B | $13.51B | Details | ||||
4/27/23 | Q123 | $2.46 | $2.46 | $0.00 | $12.23B | $12.18B | Details | ||||
2/9/23 | Q422 | $3.60 | $3.53 | +$0.07 | $15.12B | $15.33B | Details | ||||
10/28/22 | Q322 | $3.66 | $3.58 | +$0.08 | $14.81B | $14.93B | = | Details | |||
7/29/22 | Q222 | $3.37 | $3.34 | +$0.03 | $14.58B | $14.67B | = | Details |